Evidence map›Paper›PMID 28490575›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints.

Jennifer A Jacobsen, Jennifer Woodard, Malay Mandal, Marcus R Clark, Elizabeth T Bartom, Mikael Sigvardsson, Barbara L Kee

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. EZH2 coordinates memory B-cell programming and recall responses.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  3. Article
  4. The Role of Protein Methyltransferases in Immunity.Molecules (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jennifer A JacobsenCommittee on Immunology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-5354-6870
Jennifer WoodardCommittee on Immunology, The University of Chicago, Chicago, IL 60637.
Malay MandalDivision of Rheumatology, Department of Medicine, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-0451-3896
Marcus R ClarkCommittee on Immunology, The University of Chicago, Chicago, IL 60637.
Elizabeth T BartomNorthwestern University, Chicago, IL 60611.ORCID 0000-0002-5618-2582
Mikael SigvardssonDepartment of Molecular Hematology, Lund University, 22184 Lund, Sweden; and.
Barbara L KeeCommittee on Immunology, The University of Chicago, Chicago, IL 60637; bkee@bsd.uchicago.edu.
University of Chicago · USLund University · SENorthwestern University · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
Transcriptional Control of Natural Killer Cell DevelopmentR01AI106352 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2014 to 2023
$4.6M
EZH2 in lymphoid lineage specification and commitmentR21AI109233 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2014 to 2015
$435k
NCI NIH HHS P30 CA014599NIAID NIH HHS R01 AI106352NIAID NIH HHS R21 AI109233NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

The histone methyltransferase EZH2 is required for B and T cell development; however, the molecular mechanisms underlying this requirement remain elusive. In a murine model of lymphoid-specific EZH2 deficiency we found that EZH2 was required for proper development of adaptive, but not innate, lymphoid cells. In adaptive lymphoid cells EZH2 prevented the premature expression of

Indexed as

Adaptive ImmunityAnimalsB-LymphocytesCyclin-Dependent Kinase Inhibitor p16Enhancer of Zeste Homolog 2 ProteinGene Expression RegulationGenes, p53Killer Cells, NaturalLymphopoiesisMiceReceptors, AntigenT-LymphocytesCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16Enhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseReceptors, Antigen

Identifiers

PMID28490575
PMCPMC5527689
OpenAlexW2612462857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.